
Edwards Lifesciences Corporation EW
$ 79.45
-3.23%
Annual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Shares 2011-2026 | EW
Annual Shares Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 585 M | 598 M | 607 M | 619 M | 623 M | 623 M | 625 M | 628 M | 633 M | 639 M | 646 M | 639 M | 670 M | 689 M | 688 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 689 M | 585 M | 634 M |
Quarterly Shares Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 585 M | 587 M | 587 M | 589 M | 597 M | 602 M | 602 M | 601 M | 607 M | 607 M | 608 M | 608 M | 620 M | 621 M | 622 M | 624 M | 624 M | 622 M | 623 M | 624 M | 622 M | 620 M | 625 M | 209 M | 625 M | 624 M | 208 M | 208 M | 209 M | 210 M | 210 M | 210 M | 211 M | 210 M | 211 M | 212 M | 213 M | 212 M | 213 M | 215 M | 215 M | 215 M | 216 M | 108 M | 106 M | 106 M | 107 M | 109 M | 111 M | 113 M | 114 M | 114 M | 116 M | 115 M | 114 M | 114 M | 115 M | 115 M | 115 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 625 M | 106 M | 354 M |
Shares of other stocks in the Medical devices industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
14 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
67.5 M | - | - | $ 1.77 B | ||
|
Beyond Air
XAIR
|
67.7 M | $ 0.72 | 3.86 % | $ 48.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
46.7 M | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
17.8 M | - | 24.59 % | $ 44.8 M | ||
|
Dynatronics Corporation
DYNT
|
8.13 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
41.4 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
29.1 M | - | -26.83 % | $ 2.62 M | ||
|
Xtant Medical Holdings
XTNT
|
134 M | $ 0.54 | -4.43 % | $ 72.2 M | ||
|
Zimmer Biomet Holdings
ZBH
|
203 M | $ 88.29 | -0.97 % | $ 17.9 B | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Align Technology
ALGN
|
74.9 M | $ 165.93 | -6.43 % | $ 12.4 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
7.77 M | - | -5.86 % | $ 30.6 M | ||
|
Alphatec Holdings
ATEC
|
150 M | $ 10.9 | -5.43 % | $ 1.64 B | ||
|
Conformis
CFMS
|
7.22 M | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
103 M | $ 0.39 | 4.51 % | $ 40.1 M | ||
|
Abbott Laboratories
ABT
|
1.74 B | $ 104.33 | -0.23 % | $ 182 B | ||
|
Cardiovascular Systems
CSII
|
39.2 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
62.4 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
40.7 M | - | - | $ 475 M | ||
|
Boston Scientific Corporation
BSX
|
1.48 B | $ 69.42 | -1.07 % | $ 103 B | ||
|
Avinger
AVGR
|
786 K | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
37.9 M | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
81.1 K | - | 1.15 % | $ 34.5 M | ||
|
CONMED Corporation
CNMD
|
31 M | $ 34.68 | -5.35 % | $ 1.08 B | ||
|
Soliton, Inc.
SOLY
|
21.1 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
859 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
13.8 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
270 K | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
14.7 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
63 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
32.7 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.6 | -0.18 % | $ 32.7 M | ||
|
Aethlon Medical
AEMD
|
1.56 M | $ 2.14 | -5.73 % | $ 3.34 M | ||
|
BIOLASE
BIOL
|
1.28 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
135 M | $ 11.11 | -2.63 % | $ 1.5 B | ||
|
OrthoPediatrics Corp.
KIDS
|
23.5 M | $ 15.65 | -4.31 % | $ 367 M | ||
|
Invacare Corporation
IVC
|
36.5 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
1.03 M | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
41.9 M | $ 0.67 | -1.26 % | $ 28 M | ||
|
Penumbra
PEN
|
38.9 M | $ 335.28 | -0.34 % | $ 13 B | ||
|
Inspire Medical Systems
INSP
|
29.4 M | $ 49.77 | -1.35 % | $ 1.46 B | ||
|
Pulmonx Corporation
LUNG
|
40.7 M | $ 1.17 | -5.65 % | $ 47.6 M | ||
|
Cutera
CUTR
|
19.9 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
3.97 M | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
52 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
37.1 M | - | - | $ 217 M | ||
|
Surgalign Holdings
SRGA
|
6.56 M | - | -32.98 % | $ 1.68 M | ||
|
STRATA Skin Sciences
SSKN
|
34.7 M | - | - | $ 6.6 M |